Anti-VEGF treatment appears unrelated to cardiovascular risk in those with RVO
- Posted on: Aug 31 2023
- Leave a response
Patients with retinal vein occlusion (RVO) are unlikely to be at any increased cardiovascular risk due to treatment with anti-VEGF agents according to a large-scale Danish study.
Source: AAO
Posted in: Uncategorized
